Biblio
Export 1711 results:
Author [ Title
Filters: First Letter Of Last Name is C [Clear All Filters]
“Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
, “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
, “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay.”, J Alzheimers Dis, vol. 94, no. s1, pp. S399-S428, 2023.
, “Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.”, J Alzheimers Dis, vol. 79, no. 1, pp. 335-353, 2020.
, “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
, “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
, “Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.”, J Alzheimers Dis, vol. 54, no. 3, pp. 995-1004, 2016.
, “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
, “Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.”, J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
, “Oxidative Stress in Elderly with Different Cognitive Status: My Mind Project.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1405-1414, 2018.
, “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
, “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
, “Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1511-1524, 2017.
, “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
, “Our Tau Tales from Normal to Pathological Behavior.”, J Alzheimers Dis, vol. 64, no. s1, pp. S507-S516, 2018.
, “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
, “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
, “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
, “Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1479-85, 2016.
, “Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project.”, J Alzheimers Dis, vol. 87, no. 1, pp. 173-183, 2022.
, “Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.”, J Alzheimers Dis, vol. 100, no. 4, pp. 1237-1259, 2024.
, “Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1121-32, 2016.
,